FEATURED

The Hemopurifier is a U.S. Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease.

“Our smart, versatile DRX-LC delivers three powerful outcomes,” said Marco Riolfo, Worldwide Marketing Manager, Global X-ray Solutions, at Carestream. “It improves patient comfort and care by reducing the hold time and the likelihood of retakes (lowering dose). It helps improve diagnostic confidence and treatment planning by delivering improved image quality and precision; and it increases productivity and makes the image capture experience easier on radiographers.”

Medtronic introduced AccuRhythm™ AI algorithms in 2022 to patients and clinicians in Australia, countries throughout Europe, the United States, and New Zealand to help improve the accuracy of information physicians receive so they can better treat their patients.

The R-One+ robotic solution allows the interventional cardiologist to perform coronary angioplasties by controlling the devices using an integrated control command unit located in the cathlab or in the control room.